Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease (original) (raw)

• Chao, M. V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nature Rev. Neurosci. 4, 299–309 (2003).
  CAS Google Scholar
• Reichardt, L. F. Neurotrophin-regulated signalling pathways. Phil. Trans. R. Soc. B 361, 1545–1564 (2006).
  CAS PubMed PubMed Central Google Scholar
• Allen, S. J. & Dawbarn, D. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. 110, 175–191 (2006).
  CAS Google Scholar
• Chao, M. V., Rajagopal, R. & Lee, F. S. Neurotrophin signalling in health and disease. Clin. Sci. 110, 167–173 (2006).
  CAS Google Scholar
• Poduslo, J. F. & Curran, G. L. Permeability at the blood–brain and blood–nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res. Mol. Brain Res. 36, 280–286 (1996).
  CAS PubMed Google Scholar
• Saltzman, W. M., Mak, M. W., Mahoney, M. J., Duenas, E. T. & Cleland, J. L. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm. Res. 16, 232–240 (1999).
  CAS PubMed Google Scholar
• Pardridge, W. M. Neurotrophins, neuroprotection and the blood–brain barrier. Curr. Opin. Investig. Drugs 3, 1753–1757 (2002).
  CAS PubMed Google Scholar
• Fahnestock, M., Michalski, B., Xu, B. & Coughlin, M. D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell Neurosci. 18, 210–220 (2001).
  CAS PubMed Google Scholar
• Mufson, E. J. et al. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J. Neuropathol. Exp. Neurol. 71, 1018–1029 (2012).
  CAS PubMed Google Scholar
• Dyck, P. J. et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48, 501–505 (1997).
  CAS PubMed Google Scholar
• Bergmann, I., Reiter, R., Toyka, K. V. & Koltzenburg, M. Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75. Neurosci. Lett. 255, 87–90 (1998).
  CAS PubMed Google Scholar
• Aboulkassim, T. et al. Ligand-dependent TrkA activity in brain differentially affects spatial learning and long-term memory. Mol. Pharmacol. 80, 498–508 (2011).
  CAS PubMed Google Scholar
• Capsoni, S. et al. Taking pain out of NGF: a “painless” NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. PLoS ONE 6, e17321 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bai, Y. et al. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Invest. Ophthalmol. Vis. Sci. 51, 4722–4731 (2010).
  PubMed Google Scholar
• Guillemard, V. et al. An agonistic mAb directed to the TrkC receptor juxtamembrane region defines a trophic hot spot and interactions with p75 coreceptors. Dev. Neurobiol. 70, 150–164 (2010).
  CAS PubMed Google Scholar
• Ugolini, G., Marinelli, S., Covaceuszach, S., Cattaneo, A. & Pavone, F. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl Acad. Sci. USA 104, 2985–2990 (2007).
  CAS PubMed PubMed Central Google Scholar
• Sahenk, Z. et al. TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Exp. Neurol. 224, 495–506 (2010).
  CAS PubMed Google Scholar
• Blesch, A., Uy, H. S., Diergardt, N. & Tuszynski, M. H. Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factor. J. Neurosci. Res. 59, 402–409 (2000).
  CAS PubMed Google Scholar
• Taylor, L., Jones, L., Tuszynski, M. H. & Blesch, A. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J. Neurosci. 26, 9713–9721 (2006).
  CAS PubMed PubMed Central Google Scholar
• Nagahara, A. H. et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nature Med. 15, 331–337 (2009).
  CAS PubMed Google Scholar
• Chattopadhyay, M. et al. Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Mol. Ther. 12, 307–313 (2005).
  CAS PubMed Google Scholar
• Lessmann, V. & Brigadski, T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci. Res. 65, 11–22 (2009).
  CAS PubMed Google Scholar
• Santos, A. R., Comprido, D. & Duarte, C. B. Regulation of local translation at the synapse by BDNF. Prog. Neurobiol. 92, 505–516 (2010).
  CAS PubMed Google Scholar
• Skeldal, S., Matusica, D., Nykjaer, A. & Coulson, E. J. Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling? Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75NTR. Bioessays 33, 614–625 (2011).
  CAS PubMed Google Scholar
• Fenner, B. M. Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev. 23, 15–24 (2012).
  CAS PubMed Google Scholar
• Lessmann, V., Gottmann, K. & Malcangio, M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69, 341–374 (2003).
  CAS PubMed Google Scholar
• Bruno, M. A. & Cuello, A. C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl Acad. Sci. USA 103, 6735–6740 (2006).
  CAS PubMed PubMed Central Google Scholar
• Feng, D. et al. Molecular and structural insight into proNGF engagement of p75NTR and sortilin. J. Mol. Biol. 396, 967–984 (2010).
  CAS PubMed Google Scholar
• Roux, P. P., Bhakar, A. L., Kennedy, T. E. & Barker, P. A. The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276, 23097–23104 (2001).
  CAS PubMed Google Scholar
• Carter, B. D. et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272, 542–545 (1996).
  CAS PubMed Google Scholar
• Volonte, C., Angelastro, J. M. & Greene, L. A. Association of protein kinases ERK1 and ERK2 with p75 nerve growth factor receptors. J. Biol. Chem. 268, 21410–21415 (1993).
  CAS PubMed Google Scholar
• Casaccia-Bonnefil, P., Carter, B. D., Dobrowsky, R. T. & Chao, M. V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719 (1996).
  CAS PubMed Google Scholar
• Yamashita, T., Tucker, K. L. & Barde, Y. A. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24, 585–593 (1999).
  CAS PubMed Google Scholar
• Sachs, B. D. et al. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol. 177, 1119–1132 (2007).
  CAS PubMed PubMed Central Google Scholar
• Le Moan, N., Houslay, D. M., Christian, F., Houslay, M. D. & Akassoglou, K. Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. Mol. Cell 44, 476–490 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V. & Hannun, Y. A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265, 1596–1599 (1994).
  CAS PubMed Google Scholar
• Barbacid, M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann. NY Acad. Sci. 766, 442–458 (1995).
  CAS PubMed Google Scholar
• Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003).
  CAS PubMed Google Scholar
• Ip, N. Y. et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl Acad. Sci. USA 89, 3060–3064 (1992).
  CAS PubMed PubMed Central Google Scholar
• Brodeur, G. M. et al. Trk receptor expression and inhibition in neuroblastomas. Clin. Cancer Res. 15, 3244–3250 (2009).
  CAS PubMed PubMed Central Google Scholar
• Bronfman, F. C., Tcherpakov, M., Jovin, T. M. & Fainzilber, M. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J. Neurosci. 23, 3209–3220 (2003).
  CAS PubMed PubMed Central Google Scholar
• Grimes, M. L., Beattie, E. & Mobley, W. C. A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA. Proc. Natl Acad. Sci. USA 94, 9909–9914 (1997).
  CAS PubMed PubMed Central Google Scholar
• Ginty, D. D. & Segal, R. A. Retrograde neurotrophin signaling: Trk-ing along the axon. Curr. Opin. Neurobiol. 12, 268–274 (2002).
  CAS PubMed Google Scholar
• Vesa, J., Kruttgen, A. & Shooter, E. M. p75 reduces TrkB tyrosine autophosphorylation in response to brain- derived neurotrophic factor and neurotrophin 4/5. J. Biol. Chem. 275, 24414–24420 (2000).
  CAS PubMed Google Scholar
• Barker, P. A. High affinity not in the vicinity? Neuron 53, 1–4 (2007).
  CAS PubMed Google Scholar
• Urra, S. et al. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal γ-secretase-mediated release of the p75 intracellular domain. J. Biol. Chem. 282, 7606–7615 (2007).
  CAS PubMed Google Scholar
• Ceni, C. et al. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J. Cell Sci. 123, 2299–2307 (2010).
  CAS PubMed Google Scholar
• He, X. L. & Garcia, K. C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304, 870–875 (2004).
  CAS PubMed Google Scholar
• Wehrman, T. et al. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53, 25–38 (2007).
  CAS PubMed Google Scholar
• Iacaruso, M. F. et al. Structural model for p75NTR–TrkA intracellular domain interaction: a combined FRET and bioinformatics study. J. Mol. Biol. 414, 681–698 (2011).
  CAS PubMed Google Scholar
• Matusica, D. et al. An intracellular domain fragment of the p75 neurotrophin receptor (p75NTR) enhances TrkA receptor function. J. Biol. Chem. 288, 11144–11154 (2013).
  CAS PubMed PubMed Central Google Scholar
• Gong, Y., Cao, P., Yu, H. J. & Jiang, T. Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454, 789–793 (2008).
  CAS PubMed Google Scholar
• Vilar, M. et al. Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J. Cell Sci. 122, 3351–3357 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nykjaer, A. et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843–848 (2004).
  CAS PubMed Google Scholar
• Fahnestock, M. et al. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J. Neurochem. 89, 581–592 (2004).
  CAS PubMed Google Scholar
• Clewes, O. et al. Human ProNGF: biological effects and binding profiles at TrkA, p75NTR and sortilin. J. Neurochem. 107, 1124–1135 (2008).
  CAS PubMed Google Scholar
• Masoudi, R. et al. Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J. Biol. Chem. 284, 18424–18433 (2009).
  CAS PubMed PubMed Central Google Scholar
• Unsain, N., Nunez, N., Anastasia, A. & Masco, D. H. Status epilepticus induces a TrkB to p75 neurotrophin receptor switch and increases brain-derived neurotrophic factor interaction with p75 neurotrophin receptor: an initial event in neuronal injury induction. Neuroscience 154, 978–993 (2008).
  CAS PubMed Google Scholar
• Volosin, M. et al. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 26, 7756–7766 (2006).
  CAS PubMed PubMed Central Google Scholar
• Buttigieg, H., Kawaja, M. D. & Fahnestock, M. Neurotrophic activity of proNGF in vivo. Exp. Neurol. 204, 832–835 (2007).
  CAS PubMed Google Scholar
• Mufson, E. J., Brashers-Krug, T. & Kordower, J. H. p75 nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord. Brain Res. 589, 115–123 (1992).
  CAS PubMed Google Scholar
• Kordower, J. H. & Mufson, E. J. NGF receptor (p75)-immunoreactivity in the developing primate basal ganglia. J. Comp. Neurol. 327, 359–375 (1993).
  CAS PubMed Google Scholar
• Mrzljak, L. & Goldman-Rakic, P. S. Low-affinity nerve growth factor receptor (p75NGFR)- and choline acetyltransferase (ChAT)-immunoreactive axons in the cerebral cortex and hippocampus of adult macaque monkeys and humans. Cereb. Cortex 3, 133–147 (1993).
  CAS PubMed Google Scholar
• Andsberg, G., Kokaia, Z. & Lindvall, O. Upregulation of p75 neurotrophin receptor after stroke in mice does not contribute to differential vulnerability of striatal neurons. Exp. Neurol. 169, 351–363 (2001).
  CAS PubMed Google Scholar
• Beattie, M. S. et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375–386 (2002).
  CAS PubMed PubMed Central Google Scholar
• Harrington, A. W. et al. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl Acad. Sci. USA 101, 6226–6230 (2004).
  CAS PubMed PubMed Central Google Scholar
• Tep, C. et al. Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury. J. Neurosci. 33, 397–410 (2013).
  CAS PubMed PubMed Central Google Scholar
• Oh, J. D., Chartisathian, K., Chase, T. N. & Butcher, L. L. Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain. Brain Res. 853, 174–185 (2000).
  CAS PubMed Google Scholar
• Angelo, M. F. et al. p75 NTR expression is induced in isolated neurons of the penumbra after ischemia by cortical devascularization. J. Neurosci. Res. 87, 1892–1903 (2009).
  CAS PubMed Google Scholar
• Woo, N. H. et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nature Neurosci. 8, 1069–1077 (2005).
  CAS PubMed Google Scholar
• Lochner, J. E. et al. Efficient copackaging and cotransport yields postsynaptic colocalization of neuromodulators associated with synaptic plasticity. Dev. Neurobiol. 68, 1243–1256 (2008).
  CAS PubMed PubMed Central Google Scholar
• Deinhardt, K. et al. Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac. Sci. Signal. 4, ra82 (2011).
  PubMed PubMed Central Google Scholar
• Je, H. S. et al. Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses. Proc. Natl Acad. Sci. USA 109, 15924–15929 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kotlyanskaya, L., McLinden, K. A. & Giniger, E. Of proneurotrophins and their antineurotrophic effects. Sci. Signal. 6, pe6 (2013).
  PubMed PubMed Central Google Scholar
• Deinhardt, K., Reversi, A., Berninghausen, O., Hopkins, C. R. & Schiavo, G. Neurotrophins redirect p75NTR from a clathrin-independent to a clathrin-dependent endocytic pathway coupled to axonal transport. Traffic 8, 1736–1749 (2007).
  CAS PubMed Google Scholar
• Terry, A. V. Jr., Kutiyanawalla, A. & Pillai, A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol. Behav. 102, 149–157 (2011).
  CAS PubMed Google Scholar
• Peng, S., Wuu, J., Mufson, E. J. & Fahnestock, M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J. Neuropathol. Exp. Neurol. 63, 641–649 (2004).
  CAS PubMed Google Scholar
• Wang, Y. J. et al. Effects of proNGF on neuronal viability, neurite growth and amyloid-β metabolism. Neurotox. Res. 17, 257–267 (2010).
  PubMed Google Scholar
• Le, A. P. & Friedman, W. J. Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures. J. Neurosci. 32, 703–712 (2012).
  CAS PubMed PubMed Central Google Scholar
• Cuello, A. C., Bruno, M. A., Allard, S., Leon, W. & Iulita, M. F. Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation. J. Mol. Neurosci. 40, 230–235 (2010).
  CAS PubMed Google Scholar
• Serup Andersen, O. et al. Identification of a linear epitope in sortilin that partakes in pro-neurotrophin binding. J. Biol. Chem. 285, 12210–12222 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wiesmann, C., Ultsch, M. H., Bass, S. H. & de Vos, A. M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188 (1999).
  CAS PubMed Google Scholar
• Banfield, M. J. et al. Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5. Structure 9, 1191–1199 (2001).
  CAS PubMed Google Scholar
• Ibanez, C. F. Emerging themes in structural biology of neurotrophic factors. Trends Neurosci. 21, 438–444 (1998).
  CAS PubMed Google Scholar
• Arevalo, J. C. et al. TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol. Cell. Biol. 20, 5908–5916 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ohira, K., Shimizu, K. & Hayashi, M. TrkB dimerization during development of the prefrontal cortex of the macaque. J. Neurosci. Res. 65, 463–469 (2001).
  CAS PubMed Google Scholar
• Mischel, P. S. et al. Nerve growth factor signals via preexisting TrkA receptor oligomers. Biophys. J. 83, 968–976 (2002).
  CAS PubMed PubMed Central Google Scholar
• Shen, J. & Maruyama, I. N. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett. 585, 295–299 (2011).
  CAS PubMed Google Scholar
• Shen, J. & Maruyama, I. N. Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J. Mol. Signal. 7, 2 (2012).
  CAS PubMed PubMed Central Google Scholar
• Tauszig-Delamasure, S. et al. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc. Natl Acad. Sci. USA 104, 13361–13366 (2007).
  CAS PubMed PubMed Central Google Scholar
• Pitts, A. F. & Miller, M. W. Expression of nerve growth factor, p75, and trk in the somatosensory and motor cortices of mature rats: evidence for local trophic support circuits. Somatosens. Mot. Res. 12, 329–342 (1995).
  CAS PubMed Google Scholar
• Vega, J. A. et al. Immunohistochemical localization of the high-affinity NGF receptor (gp140-trkA) in the adult human dorsal root and sympathetic ganglia and in the nerves and sensory corpuscles supplying digital skin. Anat. Rec. 240, 579–588 (1994).
  CAS PubMed Google Scholar
• Boissiere, F., Faucheux, B., Ruberg, M., Agid, Y. & Hirsch, E. C. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145, 245–252 (1997).
  CAS PubMed Google Scholar
• Sofroniew, M. V., Howe, C. L. & Mobley, W. C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217–1281 (2001).
  CAS PubMed Google Scholar
• Poo, M. M. Neurotrophins as synaptic modulators. Nature Rev. Neurosci. 2, 24–32 (2001).
  CAS Google Scholar
• Yamada, K. & Nabeshima, T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267–270 (2003).
  CAS PubMed Google Scholar
• Ernfors, P., Lee, K. F., Kucera, J. & Jaenisch, R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 77, 503–512 (1994).
  CAS PubMed Google Scholar
• McMahon, S. B., Armanini, M. P., Ling, L. H. & Phillips, H. S. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12, 1161–1171 (1994).
  CAS PubMed Google Scholar
• Rabizadeh, S. & Bredesen, D. E. Ten years on: mediation of cell death by the common neurotrophin receptor p75NTR. Cytokine Growth Factor Rev. 14, 225–239 (2003).
  CAS PubMed Google Scholar
• Bamji, S. X. et al. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140, 911–923 (1998).
  CAS PubMed PubMed Central Google Scholar
• Rabizadeh, S. et al. Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345–348 (1993).
  CAS PubMed Google Scholar
• Bredesen, D. E. et al. p75NTR and the concept of cellular dependence: seeing how the other half die. Cell Death Differ. 5, 365–371 (1998).
  CAS PubMed Google Scholar
• Roux, P. P. & Barker, P. A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 67, 203–233 (2002).
  CAS PubMed Google Scholar
• Longo, F. M. & Massa, S. M. Small molecule modulation of p75 neurotrophin receptor functions. CNS Neurol. Disord. Drug Targets 7, 63–70 (2008).
  CAS PubMed Google Scholar
• Yoon, S. O., Casaccia-Bonnefil, P., Carter, B. & Chao, M. V. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18, 3273–3281 (1998).
  CAS PubMed PubMed Central Google Scholar
• Esposito, D. et al. The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J. Biol. Chem. 276, 32687–32695 (2001).
  CAS PubMed Google Scholar
• Majdan, M., Walsh, G. S., Aloyz, R. & Miller, F. D. TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal. J. Cell Biol. 155, 1275–1285 (2001).
  CAS PubMed PubMed Central Google Scholar
• Jung, K. M. et al. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J. Biol. Chem. 278, 42161–42169 (2003).
  CAS PubMed Google Scholar
• Epa, W. R., Markovska, K. & Barrett, G. L. The p75 neurotrophin receptor enhances TrkA signalling by binding to Shc and augmenting its phosphorylation. J. Neurochem. 89, 344–353 (2004).
  CAS PubMed Google Scholar
• Wilson-Gerwing, T. D., Johnston, J. M. & Verge, V. M. p75 neurotrophin receptor is implicated in the ability of neurotrophin-3 to negatively modulate activated ERK1/2 signaling in TrkA-expressing adult sensory neurons. J. Comp. Neurol. 516, 49–58 (2009).
  CAS PubMed Google Scholar
• Mi, S. et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nature Neurosci. 7, 221–228 (2004).
  CAS PubMed Google Scholar
• Wong, S. T. et al. A p75NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nature Neurosci. 5, 1302–1308 (2002).
  CAS PubMed Google Scholar
• Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R. & He, Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78 (2002).
  CAS PubMed Google Scholar
• Gauthier, L. R. et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127–138 (2004).
  CAS PubMed Google Scholar
• Chang, Q., Khare, G., Dani, V., Nelson, S. & Jaenisch, R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49, 341–348 (2006).
  CAS PubMed Google Scholar
• Gharami, K., Xie, Y., An, J. J., Tonegawa, S. & Xu, B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 105, 369–379 (2008).
  CAS PubMed Google Scholar
• Larimore, J. L. et al. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol. Dis. 34, 199–211 (2009).
  CAS PubMed PubMed Central Google Scholar
• Harris, N. G., Mironova, Y. A., Hovda, D. A. & Sutton, R. L. Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury. J. Neuropathol. Exp. Neurol. 69, 139–154 (2010).
  PubMed Google Scholar
• Boulle, F. et al. TrkB inhibition as a therapeutic target for CNS-related disorders. Prog. Neurobiol. 98, 197–206 (2012).
  CAS PubMed Google Scholar
• He, X. P. et al. Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43, 31–42 (2004).
  CAS PubMed Google Scholar
• Dinocourt, C., Gallagher, S. E. & Thompson, S. M. Injury-induced axonal sprouting in the hippocampus is initiated by activation of trkB receptors. Eur. J. Neurosci. 24, 1857–1866 (2006).
  PubMed Google Scholar
• Yasui, M. et al. Nerve growth factor and associated nerve sprouting contribute to local mechanical hyperalgesia in a rat model of bone injury. Eur. J. Pain 16, 953–965 (2012).
  CAS PubMed Google Scholar
• McKelvey, L., Shorten, G. D. & O'Keeffe, G. W. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J. Neurochem. 124, 276–289 (2013).
  CAS PubMed Google Scholar
• Scarpi, D. et al. Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity. Cell Death Dis. 3, e389 (2012).
  CAS PubMed PubMed Central Google Scholar
• Eibl, J. K., Strasser, B. C. & Ross, G. M. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor. Neurochem. Int. 61, 1266–1275 (2012).
  CAS PubMed Google Scholar
• Heinrich, C. et al. Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy. Neurobiol. Dis. 42, 35–47 (2011).
  CAS PubMed Google Scholar
• Jiang, G. & Hunter, T. Receptor signaling: when dimerization is not enough. Curr. Biol. 9, R568–R571 (1999).
  CAS PubMed Google Scholar
• Livnah, O. et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987–990 (1999).
  CAS PubMed Google Scholar
• Remy, I., Wilson, I. A. & Michnick, S. W. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990–993 (1999).
  CAS PubMed Google Scholar
• Couturier, C. & Jockers, R. Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J. Biol. Chem. 278, 26604–26611 (2003).
  CAS PubMed Google Scholar
• Ferguson, K. M. et al. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 11, 507–517 (2003).
  CAS PubMed Google Scholar
• Schlessinger, J. Signal transduction. Autoinhibition control. Science 300, 750–752 (2003).
  CAS PubMed Google Scholar
• Streaker, E. D., Gupta, A. & Beckett, D. The biotin repressor: thermodynamic coupling of corepressor binding, protein assembly, and sequence-specific DNA binding. Biochemistry 41, 14263–14271 (2002).
  CAS PubMed Google Scholar
• Ivanov, I. et al. Ligand-induced formation of transient dimers of mammalian 12/15-lipoxygenase: a key to allosteric behavior of this class of enzymes? Proteins 80, 703–712 (2012).
  CAS PubMed Google Scholar
• Arevalo, J. C. et al. A novel mutation within the extracellular domain of TrkA causes constitutive receptor activation. Oncogene 20, 1229–1234 (2001).
  CAS PubMed Google Scholar
• Spiegel, K. et al. PD 90780, a non peptide inhibitor of nerve growth factor's binding to the P75 NGF receptor. Biochem. Biophys. Res. Commun. 217, 488–494 (1995).
  CAS PubMed Google Scholar
• Jang, S. W. et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl Acad. Sci. USA 107, 2687–2692 (2010). This paper reports the identification of a flavinoid compound (7,8-DHF) that activates TRKB and that has subsequently been found to exhibit therapeutic effects in several mouse models of disease.
  CAS PubMed PubMed Central Google Scholar
• Jang, S. W. et al. Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS ONE 5, e11528 (2010).
  PubMed PubMed Central Google Scholar
• Massa, S. M. et al. Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death. J. Neurosci. 26, 5288–5300 (2006). This paper reports the first identification of small-molecule non-peptide p75 NTR ligands that modulate p75 NTR signalling towards survival in neurons and oligodendroglia.
  CAS PubMed PubMed Central Google Scholar
• Belliveau, D. J. et al. NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J. Cell Biol. 136, 375–388 (1997).
  CAS PubMed PubMed Central Google Scholar
• Saragovi, H. U. et al. A TrkA-selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals. J. Biol. Chem. 273, 34933–34940 (1998).
  CAS PubMed Google Scholar
• Minichiello, L. et al. Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses. Neuron 21, 335–345 (1998).
  CAS PubMed Google Scholar
• Xie, Y. & Longo, F. M. Neurotrophin small-molecule mimetics. Prog. Brain Res. 128, 333–347 (2000).
  CAS PubMed Google Scholar
• Pollack, S. J. & Harper, S. J. Small molecule Trk receptor agonists and other neurotrophic factor mimetics. Curr. Drug Target CNS Neurol. Disord. 1, 59–80 (2002).
  CAS Google Scholar
• Saragovi, H. U. & Zaccaro, M. C. Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites. Curr. Pharm. Des. 8, 2201–2216 (2002).
  CAS PubMed Google Scholar
• Longo, F. M., Vu, T. K. & Mobley, W. C. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul. 1, 189–195 (1990). This study is the first report of a synthetic peptide derived from NGF that can inhibit the neurotrophic activity of NGF and it illustrates the possibility of small-molecule modulation of neurotrophin signalling.
  CAS PubMed PubMed Central Google Scholar
• Ibanez, C. F. et al. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69, 329–341 (1992).
  CAS PubMed Google Scholar
• Yaar, M. et al. A cyclic peptide that binds p75NTR protects neurones from beta amyloid (1-40)-induced cell death. Neuropathol. Appl. Neurobiol. 33, 533–543 (2007).
  CAS PubMed Google Scholar
• Botchkarev, V. A., Yaar, M., Gilchrest, B. A. & Paus, R. p75 neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J. Invest. Dermatol. 120, 168–169 (2003).
  CAS PubMed Google Scholar
• Li, S. et al. Differential actions of nerve growth factor receptors TrkA and p75NTR in a rat model of epileptogenesis. Mol. Cell Neurosci. 29, 162–172 (2005).
  CAS PubMed Google Scholar
• Lebrun-Julien, F., Morquette, B., Douillette, A., Saragovi, H. U. & Di Polo, A. Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell Neurosci. 40, 410–420 (2009).
  CAS PubMed Google Scholar
• LeSauteur, L., Wei, L., Gibbs, B. F. & Saragovi, H. U. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J. Biol. Chem. 270, 6564–6569 (1995). This paper reports the competitive inhibition of NGF–TRKA binding with cyclic oligopeptides from β-turn loop 1 and loop 4 of NGF; this study supports the feasibility of developing small molecules that bind to TRKA.
  CAS PubMed Google Scholar
• Maliartchouk, S. et al. Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action. J. Biol. Chem. 275, 9946–9956 (2000).
  CAS PubMed Google Scholar
• Xie, Y., Tisi, M. A., Yeo, T. T. & Longo, F. M. Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects. J. Biol. Chem. 275, 29868–29874 (2000).
  CAS PubMed Google Scholar
• Maliartchouk, S. et al. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol. Pharmacol. 57, 385–391 (2000). This paper reports the development of a peptidomimetic ligand (compound D3) that is capable of activating TRKA and promoting neuronal survival. Compounds of this class are in clinical trials for ophthalmological disorders.
  CAS PubMed Google Scholar
• Bruno, M. A. et al. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J. Neurosci. 24, 8009–8018 (2004).
  CAS PubMed PubMed Central Google Scholar
• Shi, Z., Birman, E. & Saragovi, H. U. Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo. Dev. Neurobiol. 67, 884–894 (2007).
  CAS PubMed Google Scholar
• Colangelo, A. M. et al. A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. J. Neurosci. 28, 2698–2709 (2008).
  CAS PubMed PubMed Central Google Scholar
• O'Leary, P. D. & Hughes, R. A. Structure–activity relationships of conformationally constrained peptide analogues of loop 2 of brain-derived neurotrophic factor. J. Neurochem. 70, 1712–1721 (1998).
  PubMed Google Scholar
• O'Leary, P. D. & Hughes, R. A. Design of potent peptide mimetics of brain-derived neurotrophic factor. J. Biol. Chem. 278, 25738–25744 (2003). This paper reports the synthesis of a tricyclic oligopeptide dimer based on a BDNF domain; this was the first BDNF-derived molecule to exhibit neurotrophic activity, and this study indicates the possibility of developing small molecules with BDNF-like activity.
  PubMed Google Scholar
• Cardenas- Aguayo Mdel, C., Kazim, S. F., Grundke-Iqbal, I. & Iqbal, K. Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures. PLoS ONE 8, e53596 (2013).
  Google Scholar
• Fletcher, J. M. et al. Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor. J. Biol. Chem. 283, 33375–33383 (2008).
  CAS PubMed PubMed Central Google Scholar
• Xiao, J. et al. A small peptide mimetic of brain-derived neurotrophic factor promotes peripheral myelination. J. Neurochem. 125, 386–398 (2013).
  CAS PubMed Google Scholar
• Cazorla, M. et al. Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. PLoS ONE 5, e9777 (2010).
  PubMed PubMed Central Google Scholar
• Pattarawarapan, M., Zaccaro, M. C., Saragovi, U. H. & Burgess, K. New templates for syntheses of ring-fused, C10 β-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3. J. Med. Chem. 45, 4387–4390 (2002).
  CAS PubMed Google Scholar
• Zhang, A. J., Khare, S., Gokulan, K., Linthicum, D. S. & Burgess, K. Dimeric β-turn peptidomimetics as ligands for the neurotrophin receptor TrkC. Bioorg. Med. Chem. Lett. 11, 207–210 (2001).
  CAS PubMed Google Scholar
• Lin, B. et al. Neuroprotection by small molecule activators of the nerve growth factor receptor. J. Pharmacol. Exp. Ther. 322, 59–69 (2007).
  CAS PubMed Google Scholar
• Jang, S. W. et al. Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc. Natl Acad. Sci. USA 104, 16329–16334 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zhang, B. et al. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284, 974–977 (1999).
  CAS PubMed Google Scholar
• Jang, S. W. et al. Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem. Biol. 16, 644–656 (2009).
  CAS PubMed PubMed Central Google Scholar
• Fuh, G., Li, B., Crowley, C., Cunningham, B. & Wells, J. A. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem. 273, 11197–11204 (1998).
  CAS PubMed Google Scholar
• Clackson, T. & Wells, J. A. A hot spot of binding energy in a hormone–receptor interface. Science 267, 383–386 (1995).
  CAS PubMed Google Scholar
• Angell, Y., Chen, D., Brahimi, F., Saragovi, H. U. & Burgess, K. A combinatorial method for solution-phase synthesis of labeled bivalent β-turn mimics. J. Am. Chem. Soc. 130, 556–565 (2008).
  CAS PubMed Google Scholar
• Chen, J. et al. Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity. Neurosci. Lett. 499, 181–185 (2011).
  CAS PubMed Google Scholar
• Devi, L. & Ohno, M. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 37, 434–444 (2012).
  CAS PubMed Google Scholar
• Andero, R. et al. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am. J. Psychiatry 168, 163–172 (2011).
  PubMed Google Scholar
• Andero, R., Daviu, N., Escorihuela, R. M., Nadal, R. & Armario, A. 7,8-dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats. Hippocampus 22, 399–408 (2012).
  CAS PubMed Google Scholar
• Zeng, Y. et al. Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J. Neurosci. 31, 17800–17810 (2011).
  CAS PubMed PubMed Central Google Scholar
• Blugeot, A. et al. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J. Neurosci. 31, 12889–12899 (2011).
  CAS PubMed PubMed Central Google Scholar
• Liu, X. et al. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J. Med. Chem. 53, 8274–8286 (2010).
  CAS PubMed PubMed Central Google Scholar
• Liu, X. et al. Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression. J. Med. Chem. 55, 8524–8537 (2012).
  CAS PubMed PubMed Central Google Scholar
• Johnson, R. A. et al. 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome. J. Appl. Physiol. 112, 704–710 (2012).
  CAS PubMed Google Scholar
• Massa, S. M. et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J. Clin. Invest. 120, 1774–1785 (2010).
  CAS PubMed PubMed Central Google Scholar
• Schmid, D. A. et al. A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J. Neurosci. 32, 1803–1810 (2012).
  CAS PubMed PubMed Central Google Scholar
• Han, J. et al. Delayed administration of a small molecule tropomyosin-related kinase B ligand promotes recovery after hypoxic-ischemic stroke. Stroke 43, 1918–1924 (2012).
  CAS PubMed PubMed Central Google Scholar
• Prince, D. A. et al. Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis. Epilepsia 50 (Suppl. 2), 30–40 (2009).
  PubMed PubMed Central Google Scholar
• Li, H. et al. Targets for preventing epilepsy following cortical injury. Neurosci. Lett. 497, 172–176 (2011).
  CAS PubMed PubMed Central Google Scholar
• Cazorla, M. et al. Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J. Clin. Invest. 121, 1846–1857 (2011). This studyestablishes the feasibility of developing drug-like TRKB antagonists and their application in vivo.
  CAS PubMed PubMed Central Google Scholar
• Spaeth, A. M., Kanoski, S. E., Hayes, M. R. & Grill, H. J. TrkB receptor signaling in the nucleus tractus solitarius mediates the food intake-suppressive effects of hindbrain BDNF and leptin. Am. J. Physiol. Endocrinol. Metab. 302, E1252–E1260 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ren, Q. et al. Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine. Pharmacol. Biochem. Behav. 106, 124–127 (2013).
  CAS PubMed Google Scholar
• Jang, S. W. et al. _N_-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc. Natl Acad. Sci. USA 107, 3876–3881 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shen, J. et al. _N_-acetyl serotonin derivatives as potent neuroprotectants for retinas. Proc. Natl Acad. Sci. USA 109, 3540–3545 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chen, D. et al. Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals. ACS Chem. Biol. 4, 769–781 (2009).
  CAS PubMed PubMed Central Google Scholar
• Longo, F. M., Manthorpe, M., Xie, Y. M. & Varon, S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J. Neurosci. Res. 48, 1–17 (1997).
  CAS PubMed Google Scholar
• Pehar, M. et al. Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain. Eur. J. Neurosci. 24, 1575–1580 (2006).
  PubMed Google Scholar
• Yang, T. et al. Small molecule, non-peptide p75 ligands inhibit Aβ-induced neurodegeneration and synaptic impairment. PLoS ONE 3, e3604 (2008).
  PubMed PubMed Central Google Scholar
• Knowles, J. K. et al. A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. Neurobiol. Aging 34, 2052–2063 (2013).
  CAS PubMed Google Scholar
• Bachis, A. & Mocchetti, I. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann. NY Acad. Sci. 1053, 247–257 (2005).
  CAS PubMed Google Scholar
• Meeker, R. B., Poulton, W., Feng, W. H., Hudson, L. & Longo, F. M. Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model. J. Neuroimmune Pharmacol. 7, 388–400 (2012).
  PubMed Google Scholar
• Lu, Q., Longo, F. M., Zhou, H., Massa, S. M. & Chen, Y. H. Signaling through Rho GTPase pathway as viable drug target. Curr. Med. Chem. 16, 1355–1365 (2009).
  CAS PubMed PubMed Central Google Scholar
• James, S. E. et al. Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants. Neurotoxicology 29, 605–612 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bai, Y. et al. Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J. Biol. Chem. 285, 39392–39400 (2010).
  CAS PubMed PubMed Central Google Scholar
• Thoenen, H. & Sendtner, M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nature Neurosci. 5, S1046–S1050 (2002).
  Google Scholar
• Eriksdotter Jonhagen, M. et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9, 246–257 (1998).
  CAS PubMed Google Scholar
• Jones, M. G., Munson, J. B. & Thompson, S. W. A role for nerve growth factor in sympathetic sprouting in rat dorsal root ganglia. Pain 79, 21–29 (1999).
  CAS PubMed Google Scholar
• Pertovaara, A. Noradrenergic pain modulation. Prog. Neurobiol. 80, 53–83 (2006).
  CAS PubMed Google Scholar
• Apfel, S. C. et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. JAMA 284, 2215–2221 (2000).
  CAS PubMed Google Scholar
• Wellmer, A., Misra, V. P., Sharief, M. K., Kopelman, P. G. & Anand, P. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J. Peripher. Nerv. Syst. 6, 204–210 (2001).
  CAS PubMed Google Scholar
• McArthur, J. C. et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 54, 1080–1088 (2000).
  CAS PubMed Google Scholar
• Schifitto, G. et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 57, 1313–1316 (2001).
  CAS PubMed Google Scholar
• [No authors listed.] A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology 52, 1427–1433 (1999).
• Yaar, M. et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J. Clin. Invest. 100, 2333–2340 (1997).
  CAS PubMed PubMed Central Google Scholar
• Yaar, M. et al. Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 277, 7720–7725 (2002).
  CAS PubMed Google Scholar
• Costantini, C. et al. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in β-amyloid peptide-dependent cell death. J. Mol. Neurosci. 25, 141–156 (2005).
  CAS PubMed Google Scholar
• Dinamarca, M. C., Rios, J. A. & Inestrosa, N. C. Postsynaptic receptors for amyloid-β oligomers as mediators of neuronal damage in Alzheimer's disease. Front. Physiol. 3, 464 (2012).
  PubMed PubMed Central Google Scholar
• Shankar, G. M. & Walsh, D. M. Alzheimer's disease: synaptic dysfunction and Aβ. Mol. Neurodegener. 4, 48 (2009).
  PubMed PubMed Central Google Scholar
• Shelton, D. L. et al. Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J .Neurosci. 15, 477–491 (1995).
  CAS PubMed PubMed Central Google Scholar
• Jain, P. et al. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye. Exp. Eye Res. 93, 503–512 (2011).
  CAS PubMed Google Scholar